These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2911129)

  • 1. Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.
    Rodriguez JF; Esteban M
    J Virol; 1989 Feb; 63(2):997-1001. PubMed ID: 2911129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus.
    Dallo S; Rodriguez JF; Esteban M
    Virology; 1987 Aug; 159(2):423-32. PubMed ID: 2441522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    Blasco R; Moss B
    J Virol; 1991 Nov; 65(11):5910-20. PubMed ID: 1920620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of vaccinia MVA recombinants using the viral F13L gene as the selective marker.
    Sánchez-Puig JM; Blasco R
    Biotechniques; 2005 Nov; 39(5):665-6, 668, 670 passim. PubMed ID: 16312215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.
    Franke CA; Rice CM; Strauss JH; Hruby DE
    Mol Cell Biol; 1985 Aug; 5(8):1918-24. PubMed ID: 3018537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of recombinant vaccinia viruses on the basis of plaque formation.
    Blasco R; Moss B
    Gene; 1995 Jun; 158(2):157-62. PubMed ID: 7607536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface.
    Rodger G; Smith GL
    J Gen Virol; 2002 Feb; 83(Pt 2):323-332. PubMed ID: 11807225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single point mutation of Ala-25 to Asp in the 14,000-Mr envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus.
    Gong SC; Lai CF; Dallo S; Esteban M
    J Virol; 1989 Nov; 63(11):4507-14. PubMed ID: 2795709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.
    Roper RL; Wolffe EJ; Weisberg A; Moss B
    J Virol; 1998 May; 72(5):4192-204. PubMed ID: 9557708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertional inactivation of a fowlpox virus homologue of the vaccinia virus F12L gene inhibits the release of enveloped virions.
    Ogawa R; Calvert JG; Yanagida N; Nazerian K
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():55-64. PubMed ID: 8380837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant.
    Traktman P; Liu K; DeMasi J; Rollins R; Jesty S; Unger B
    J Virol; 2000 Apr; 74(8):3682-95. PubMed ID: 10729144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
    Ortiz MA; Paez E
    Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant host range selection of vaccinia recombinants by rescue of an essential gene.
    Holzer GW; Gritschenberger W; Mayrhofer JA; Wieser V; Dorner F; Falkner FG
    Virology; 1998 Sep; 249(1):160-6. PubMed ID: 9740787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
    Herrera E; Lorenzo MM; Blasco R; Isaacs SN
    J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of second-site mutations that enhance release and spread of vaccinia virus.
    Katz E; Wolffe E; Moss B
    J Virol; 2002 Nov; 76(22):11637-44. PubMed ID: 12388724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance.
    Hansen SG; Cope TA; Hruby DE
    Biotechniques; 2002 May; 32(5):1178, 1180, 1182-7. PubMed ID: 12019792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.
    Weir JP; Bajszár G; Moss B
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1210-4. PubMed ID: 6280173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marker rescue of temperature-sensitive mutations of vaccinia virus WR: correlation of genetic and physical maps.
    Ensinger MJ; Rovinsky M
    J Virol; 1983 Nov; 48(2):419-28. PubMed ID: 6312100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient selection during vaccinia virus recombination with insertion vectors without selectable markers.
    Kurilla MG
    Biotechniques; 1997 May; 22(5):906-10. PubMed ID: 9149873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses.
    Rodriguez D; Rodriguez JR; Rodriguez JF; Trauber D; Esteban M
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1287-91. PubMed ID: 2784004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.